Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Analyzing a defense and nuclear technology company requires attention to segment-level disclosures, contract backlog details, and government procurement dependencies. Curtiss-Wright Corporation's SEC filings reveal how its three business divisions—Aerospace and Industrial, Defense Electronics, and Naval and Power—contribute to overall financial performance.
The company's 10-K annual reports break down revenue, operating income, and asset allocation across segments. For a company serving defense departments, nuclear utilities, and commercial aerospace manufacturers, understanding customer concentration and contract timing proves essential. The 10-K's backlog disclosures indicate future revenue visibility, while segment margin analysis shows which divisions generate the strongest returns.
Quarterly 10-Q filings track sequential changes in segment performance, particularly important for a company with exposure to government budget cycles and long-cycle commercial contracts. Our AI-powered summaries highlight quarter-over-quarter changes in revenue recognition, margin trends, and management commentary on order activity.
Form 4 insider transactions document when executives and directors buy or sell Curtiss-Wright shares. For a mid-cap industrial company, insider activity can signal management confidence in upcoming contract awards or operational improvements. Track these transactions alongside earnings announcements to understand executive perspectives on company prospects.
The company's 8-K filings cover material events including acquisition announcements, significant contract awards, dividend declarations, and share repurchase authorizations. DEF 14A proxy statements detail executive compensation structures and governance practices. Our platform delivers real-time EDGAR updates with AI analysis that explains the significance of each filing for Curtiss-Wright's defense electronics, nuclear power, and aerospace businesses.
Curtiss-Wright Corp director Peter C. Wallace reported a charitable gift of 200 shares of the company’s common stock. The transaction took place on December 11, 2025 and is coded as a bona fide gift, with a reported price of $0 because no sale occurred.
The shares were donated to a donor advised fund that will use them for charitable purposes. After this donation, Wallace beneficially owns 5,007 shares of Curtiss-Wright common stock, held directly, and he has no beneficial interest, control, or dispositive power over the gifted shares or the donor advised fund.
Curtiss-Wright Corporation reported an insider stock transaction by its Chair and CEO, who is also a director. On 12/11/2025, the reporting person made a bona fide gift of 184 shares of common stock, reducing their directly held beneficial ownership to 35,229 shares. The shares were donated to a donor advised fund for charitable purposes.
According to the disclosure, the reporting person no longer has beneficial interest, control, or dispositive power over the gifted shares or the donor advised fund. The transaction was recorded as a gift with a price entry of zero, reflecting that there was no sale involved, only a transfer for charity.
Curtiss-Wright Corporation director reports stock gift
A director of Curtiss-Wright Corporation reported a bona fide gift of 2,000 shares of common stock on 12/11/2025. The shares were given to irrevocable trusts established for the benefit of the reporting person’s children. Neither the reporting person nor his spouse are trustees or beneficiaries of these trusts, and the reporting person has no beneficial or pecuniary interest in the trust assets.
Following this gift, the director directly holds 13,567.85 shares of Curtiss-Wright common stock. The transaction is coded as a gift and carries a price of $0, reflecting that it was a non-cash transfer for estate or family planning purposes rather than an open-market sale.
Curtiss-Wright Corporation insider transaction: A company officer, serving as Vice President of Strategy and Business Development, reported selling 175 shares of Curtiss-Wright common stock on 11/25/2025 at a price of $546.97 per share. After this sale, the reporting person beneficially owns 3,688 shares of Curtiss-Wright common stock.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that the reporting person adopted on August 26, 2025 and that is maintained by the reporting person’s financial advisor. The filing also notes that the shares were sold in compliance with the company’s share ownership guidelines, which allow sales as long as the officer remains in compliance with those ownership requirements.
Curtiss-Wright (CW)Merrill, located at 6000 Fairview Rd., Suite 600, Charlotte, NC 28210, on the NYSE around 11/25/2025, with an aggregate market value of $391,472. The filing states that there were 36,847,638 shares of this class outstanding.
The shares to be sold were originally acquired from the company as stock-based compensation. One grant of common stock was acquired on 02/07/2024 as a stock bonus for 400 shares, and another on 03/18/2024 as a stock bonus for 288 shares, with both transactions described as stock bonus payments on their respective dates.
Curtiss-Wright Corporation announced that its Board of Directors has authorized the company to repurchase up to an additional $416 million of its common stock, bringing the total available share repurchase authorization to $550 million, including $134 million remaining from prior programs. The company may repurchase shares through methods such as open market purchases, accelerated share repurchase transactions, negotiated block trades, Rule 10b5-1 plans, and other brokered or privately negotiated transactions.
The company also adopted two Rule 10b5-1 trading plans that begin on January 2, 2026 and end on December 31, 2026. One plan contemplates purchases totaling $60 million executed evenly over calendar year 2026, while a second plan provides for potential purchases up to $100 million, subject to a price limit that could prevent purchases. A designated broker will execute repurchases under these plans, and future periodic reports will provide updates on actual share repurchase activity.
Curtiss-Wright Corporation (CW) Chair and CEO Lynn M. Bamford reported an open market sale of company stock. On 11/14/2025, 3,750 shares of Curtiss-Wright common stock were sold at an average price of $549.07 per share. After this transaction, the reporting person beneficially owns 35,413 shares of Curtiss-Wright common stock in direct form. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2025 and is stated to comply with the company’s share ownership guidelines.
Form 144 filing indicates a proposed sale of CW common stock. The notice lists 3,750 shares to be sold through UBS Financial Services, Inc., with an aggregate market value of $2,008,968.00. The approximate sale date is 11/14/2025, and the securities are listed on the NYSE.
The shares to be sold were acquired as RSUs on 02/05/2024 from the issuer, in the amount of 3,750. Shares outstanding are shown as 36,874,638. The recent sales section reports that Lynn Bamford sold 3,750 common shares on 11/11/2025 for gross proceeds of $2,166,705.75.
Curtiss-Wright (CW) insider transaction: Vice President and CFO K. Christopher Farkas reported an open market sale of 5,047 shares of common stock on 11/11/2025 at an average price of $577.91, coded “S.” The sale was executed under a Rule 10b5-1 trading plan adopted on August 11, 2025 and complies with the company’s share ownership guidelines.
Following the sale, the officer directly owns 4,236 shares. The filing notes the shares were sold in multiple trades within a price range of $574.14 to $579.17, and the reporting person will provide full trade details upon request.
Curtiss-Wright (CW) reported an insider transaction by Chair and CEO (and Director) Lynn M. Bamford. On 11/11/2025, the reporting person sold 3,750 shares of common stock at an average price of $577.79, with trades executed between $573.46 and $577.33. Following the sale, the reporting person beneficially owns 39,163 shares directly. The sale was conducted under a Rule 10b5-1 trading plan adopted on August 12, 2025 and in compliance with the company’s share ownership guidelines.